RecruitingEarly Phase 1NCT05665465

Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking


Sponsor

Duke University

Enrollment

150 participants

Start Date

Jan 19, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to evaluate how certain childhood experiences influences brain function and responses to nicotine exposure in a group of nonsmoking young adults. The investigators assess responses to nicotine exposure by giving participants a small amount of nicotine or placebo, and then asking them to answer questionnaires. The investigational drugs used in this study are a nicotine nasal spray (i.e., Nicotrol) and/or a nasal spray placebo (made of common kitchen ingredients, including a very tiny amount of pepper extract also called capsaicin). The investigators assess brain function through function magnetic resonance imaging (fMRI), which is a noninvasive procedure that uses a magnetic field to take pictures of your brain while you are performing certain tasks. This study will help us to learn more about why some childhood experiences (adverse childhood experiences, or ACEs) contribute to increased risk for smoking and other substance use.


Eligibility

Min Age: 18 YearsMax Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Nicotine nasal spray 0.5 mg and a drug called Placebo for people with adverse childhood experiences and nicotine dependence, cigarettes. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 21 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNicotine nasal spray 0.5 mg

Participants will be administered nicotine nasal spray and provide subjective reactions

DRUGPlacebo

Participants will be administered placebo nasal spray and provide subjective reactions


Locations(1)

Duke University Medical Center

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05665465


Related Trials